BOBCAT Trademark

Trademark Overview

On Tuesday, October 3, 2023, a trademark application was filed for BOBCAT with the United States Patent and Trademark Office. The USPTO has given the BOBCAT trademark a serial number of 98207353. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, July 30, 2024. This trademark is owned by Elixirgen Therapeutics, Inc.. The BOBCAT trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding proteins for treating or preventing genetic diseases; pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding proteins for treating or preventing infectious diseases; pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding proteins for treating or preventing cancers; pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding proteins for treating or preventing age-related diseases; pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding ribonucleoprotein constructs for gene editing being for the treatment of genetic disorders; pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding ribonucleoprotein constructs for treating genetic disorders in the nature of telomere shortening; pharmaceutical preparations, namely, RNA dos...

Development of pharmaceutical products for others; pharmaceutical product quality testing and evaluation for others; research and development of pharmaceutical products for others; research and development of medical products for others; research and development of pharmaceuticals for the treatment of age-related diseases and cancer; pharmaceutical products development; pharmaceutical research services; pharmaceutical research and development; research and development in the pharmaceutical and biotechnology fields; research and development in the field of medical products
bobcat

General Information

Serial Number98207353
Word MarkBOBCAT
Filing DateTuesday, October 3, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, July 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 30, 2024

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding proteins for treating or preventing genetic diseases; pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding proteins for treating or preventing infectious diseases; pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding proteins for treating or preventing cancers; pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding proteins for treating or preventing age-related diseases; pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding ribonucleoprotein constructs for gene editing being for the treatment of genetic disorders; pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding ribonucleoprotein constructs for treating genetic disorders in the nature of telomere shortening; pharmaceutical preparations, namely, RNA dosage medium preparations carrying genes encoding proteins for regenerative medicine in the nature of cell rejuvenation
Goods and ServicesDevelopment of pharmaceutical products for others; pharmaceutical product quality testing and evaluation for others; research and development of pharmaceutical products for others; research and development of medical products for others; research and development of pharmaceuticals for the treatment of age-related diseases and cancer; pharmaceutical products development; pharmaceutical research services; pharmaceutical research and development; research and development in the pharmaceutical and biotechnology fields; research and development in the field of medical products

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 12, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 12, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameElixirgen Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBaltimore, MD 21205
Party NameElixirgen Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBaltimore, MD 21205

Trademark Events

Event DateEvent Description
Friday, October 6, 2023NEW APPLICATION ENTERED
Thursday, October 12, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 23, 2024ASSIGNED TO EXAMINER
Wednesday, May 29, 2024NON-FINAL ACTION E-MAILED
Wednesday, May 29, 2024NON-FINAL ACTION WRITTEN
Wednesday, May 29, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 20, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 20, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 20, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 21, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 10, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 30, 2024PUBLISHED FOR OPPOSITION
Tuesday, July 30, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Related Keywords

bobcat pharmaceutical preparations development research namely encoding carrying dosage medium genes